Evaxion A (EVAX) Retained Earnings (2019 - 2026)
Evaxion A (EVAX) posted Retained Earnings of -$133.7 million for Q1 2026, down 5.93% on a QoQ basis from -$126.2 million in Q4 2025, and down 11.33% year-over-year from -$150.8 million in Q1 2025.
Evaxion A (EVAX) Retained Earnings (2019 - 2026) Analysis & Trends
Evaxion A's Retained Earnings history runs 8 years deep, the most recent figure standing at -$133.7 million for Q1 2026.
- Quarterly Retained Earnings fell 11.33% year-over-year to -$133.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$133.7 million (down 11.33% YoY) and the FY2025 annual result came in at -$126.2 million, down 6.5% from the prior year.
- Retained Earnings was -$133.7 million for Q1 2026 at Evaxion A, down from -$126.2 million in the prior quarter.
- Across five years, Retained Earnings topped out at $97.3 million in Q4 2023 and bottomed at -$112.0 billion in Q1 2024.
- A 5-year average of -$7.1 billion and a median of -$101.4 million in 2023 frame the typical range for Retained Earnings.
- Annual changes were most pronounced in 2023 — Retained Earnings soared 213.39% — and 2024, when it plunged 142214.73%.
- Evaxion A's Retained Earnings stood at -$85.8 million in 2022, then surged by 213.39% to $97.3 million in 2023, then tumbled by 221.77% to -$118.5 million in 2024, then declined by 6.5% to -$126.2 million in 2025, then slipped by 5.93% to -$133.7 million in 2026.
- Business Quant data shows EVAX's Retained Earnings at -$133.7 million in Q1 2026, -$126.2 million in Q4 2025, and -$127.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | Evaxion A | 25.44 Mn | 25.44 Mn | - | -133.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -133.72 Mn |
| Dec 31, 2025 | -126.24 Mn |
| Sep 30, 2025 | -127.32 Mn |
| Jun 30, 2025 | -124.95 Mn |
| Mar 31, 2025 | -120.11 Mn |
| Dec 31, 2024 | -118.54 Mn |
| Jun 30, 2024 | -112.97 Mn |
| Mar 31, 2024 | -112.03 Bn |
| Dec 31, 2023 | 97.34 Mn |
| Sep 30, 2023 | -89.76 Mn |
| Jun 30, 2023 | -84.26 Mn |
| Mar 31, 2023 | -78.72 Mn |
| Dec 31, 2022 | -85.85 Mn |
| Sep 30, 2022 | -65.76 Mn |
| Jun 30, 2022 | -60.33 Mn |
| Mar 31, 2022 | -55.88 Mn |
| Dec 31, 2021 | 79.11 Mn |
| Sep 30, 2021 | -42.14 Mn |
| Jun 30, 2021 | -37.47 Mn |
| Mar 31, 2021 | -31.08 Mn |